Glucagon-like peptide-1 receptor signaling modifies the extent of diabetic kidney disease through dampening the receptor for advanced glycation end products–induced inflammationKarly C. Sourris, Melinda T. Coughlan, Assam El‐Osta et al.|Kidney International|2023Cited by 121